J&J formally shakes on $4bn deal for diagnostics unit
This article was originally published in Clinica
Executive Summary
Johnson & Johnson officially accepted the binding offer from private equity firm, The Carlyle Group, to acquire its Ortho-Clinical Diagnostics unit for $4.15bn.